Angiogenic growth factorspotential new treatment for acute myocardial infarction?

Cardiovascular Research

Volumn 45, Issue 2, 2000, Pages 294-302

  Gonçalves, Lino M ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Collateral circulation; Growth factors; Necrosis

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; HEPARIN; SOMATOMEDIN B; SOMATOMEDIN C; GROWTH PROMOTOR; SOMATOMEDIN;

ANGIOGENESIS; APOPTOSIS; BLOOD CLOT LYSIS; CAT; COLLATERAL CIRCULATION; DOG; HEART INFARCTION; HEART MUSCLE PERFUSION; HEART PROTECTION; HUMAN; LIMB ISCHEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RAT; REVIEW; SWINE; ANIMAL; PATHOPHYSIOLOGY;

ANIMALS; COLLATERAL CIRCULATION; FIBROBLAST GROWTH FACTORS; GROWTH SUBSTANCES; HUMANS; MYOCARDIAL INFARCTION; SOMATOMEDINS;

EID: 0033625185     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00358-2     Document Type: Review

References (104)

1. Heart facts. 1987;American Heart Association National Center, Dallas.
2. Braunwald E. Efforts to limit myocardial infarct size: Historical considerations. Eur Heart J. 6:(Suppl E):1985;1-4.
3. Bussmann W.D., Passek D., Seidel W., Kaltenbach M. Reduction of CK and CK-MB indexes of infarct size by intravenous nitroglycerine. Circulation. 63:1981;615-622.
4. Reduction of infarct size with the early use of timolol in acute myocardial infarction. New Engl J Med. 310:1984;9-15.
5. DeWood M.A., Stifter W.F., Rudy L.W., Hinnen M.L. Bypass surgery in acute myocardial infarction. Eur Heart J. 6:(Suppl. E):1985;43-52.
6. Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet. 2:1987;871-874.
7. Grines C.L., Browne K.F., Marco J., et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. New Engl J Med. 328:1993;673-679.
8. Holman B.L., Chisholm R J., Braunwald E. The prognostic implications of acute myocardial infarct scintigraphy with 99mTc-pyrophosphate. Circulation. 57:1978;320-326.
9. Rude R.E., Muller J.E., Braunwald E. Efforts to limit the size of myocardial infarcts. Ann Intern Med. 95:1981;736-761.
10. Granger H.J., Ziche M., Hawker J.R. Jr. Molecular and cellular basis of myocardial angiogenesis. Cell Mol Biol Res. 40:1994;81-85.
11. Moscatelli D., Presta M., Rifkin D.B. Purification of a factor from human placenta that stimulates capillary endothelial cell protease production. DNA synthesis, and migration. Proc Natl Acad Sci USA. 83:1986;2091-2095.
12. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246:1989;1306-1309.
13. Connolly D.T., Hewelman D.M., Nelson R., et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest. 84:1989;1470-1478.
14. Kluge A., Zimmermann R., Weihrauch D., et al. Coordinate expression of the insulin-like growth factor system after microembolisation in porcine heart. Cardiovasc Res. 33:1997;324-331.
15. Kluge A., Zimmermann R., Munkel B., et al. Insulin-like growth factor I is involved in inflammation linked angiogenic processes after microembolisation in porcine heart. Cardiovasc Res. 29:1995;407-415.
16. Banai S., Jaklitsch M.T., Shou M., et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 89:1994;2183-2189.
17. Pearlman J.D., Hibberd M.G., Chuang M.L., et al. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med. 1:1995;1085-1089.
18. Banai S., Jaklitsch M.T., Casscells W., et al. Effects of acidic fibroblast growth factor on normal and ischemic myocardium. Circ Res. 69:1991;76-85.
19. Unger E.F., Banai S., Shou M., et al. A model to assess interventions to improve collateral blood flow: continuous administration of agents into the left coronary artery in dogs. Cardiovasc Res. 27:1993;785-791.
20. Yanagisawa-Miwa A., Uchida Y., Nakamura F., et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science. 257:1992;1401-1403.
21. Battler A., Scheinowitz M., Bor A., et al. Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium. J Am Coll Cardiol. 22:1993;2001-2006.
22. Uchida Y., Yanagisawa-Miwa A., Nakamura F., et al. Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparin sulfate: an experimental study. Am Heart J. 130:1995;1182-1188.
23. Franco W.P., Bracey A.W., Franco K.L., Hufnagel Caglogar D.H., Kloner R.A. Fibroblast growth factor and infarct size. Ann Intern Med. 93:1980;637-638.
24. Unger E.F., Banai S., Shou M., et al. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol. 266:(4 Pt 2):1994;H1588-H595.
25. McGrory W.J., Bautista D.S., Graham F.L. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology. 163:1988;614-617.
26. Peters K.G., De Vries C., Williams L.T. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA. 90:1993;8915-8919.
27. Cuevas P., Carceller F., Ortega S., et al. Hypotensive activity of fibroblast growth factor. Science. 254:1991;1208-1210.
28. Lopez J.J., Laham R.J., Carrozza J.P., et al. Hemodynamic effects of intracoronary VEGF delivery: evidence of tachyphylaxis and NO dependence of response. Am J Physiol. 273:(3 Pt 2):1997;H1317-H1323.
29. Anderson K.J., Dam D., Lee S., Cotman C.W. Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo. Nature. 332:1988;360-363.
30. Cuevas P., Carceller F., Lozano R.M., et al. Protection of rat myocardium by mitogenic and non-mitogenic fibroblast growth factor during post-ischemic reperfusion. Growth Factors. 15:1997;29-40.
31. Goncalves L.M. Fibroblast growth factor-mediated angiogenesis for the treatment of ischemia. Lessons learned from experimental models and early human experience. Rev Port Cardiol. 17:(Suppl 2):1998;II11-II20.
32. Van Belle E., Bauters C., Bertrand M.E. From the angiogenic response to ischemia to the validation of the concept of 'therapeutic angiogenesis'. Arch Mal Coeur Vaiss. 91:1998;1159-1170.
33. Bauters C. Growth factors as a potential new treatment for ischemic heart disease. Clin Cardiiol. 20:(11 Suppl 2):1997;II52-II57.
34. Schaper W., Schaper J., Pasyk S. Development of a colateral circulation in chronic experimental coronary occlusion. Lichtlen P.R. Coronary angiography and angina pectoris. 1976;325-333 Georg Thiem, Stuttgart.
35. Schaper W., Sharma H.S., Quinkler W., et al. Molecular biologic concepts of coronary anastomoses. J Am Coll Cardiol. 15:1990;513-518.
36. Bishop S.P., White F.C., Bloor C.M. Regional myocardial blood flow during acute myocardial infarction in the conscious dog. Circ Res. 38:1976;429-438.
37. Becker L.C., Pitt B. Collateral blood flow in conscious dogs with chronic coronary artery occlusion. Am J Physiol. 221:1971;1507-1510.
38. Kumar S., Shahabuddin S., Haboubi N., West D., Arnold F., Reid H. Angiogenesis factor from human myocardial infarcts. Lancet. 2:1983;364-367.
39. Reimer K.A., Jennings R.B. The wavefront phenomenon of myocardial ischemic cell death. Lab Invest. 40:1979;633-644.
40. Schaper W., De Brabander M., Lewi P. DNA synthesis and mitoses in coronary collateral vessels of the dog. Circ Res. 28:1971;671-679.
41. Sabia P.J., Powers E.R., Ragosta M., et al. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. New Engl J Med. 327:1992;1825-1831.
42. Sasayama S., Fujita M. Recent insights into coronary collateral circulation. Circulation. 85:1992;1197-1204.
43. Williams D.O., Amsterdam E.A., Miller R.R., Mason D.T. Functional significance of coronary collateral vessels in patients with acute myocardial infarction: relation to pump performance, cardiogenic shock and survival. Am J Cardiol. 37:1976;345-351.
44. Hirai T., Fujita M., Nakajima H., et al. Importance of collateral circulation for prevention of left ventricular aneurysm formation in acute myocardial infarction. Circulation. 79:1989;791-796.
45. Shammas N.W., Moss A.J., Sullebarger J.T., Gutierrez O.H., Rocco T.A. Acquired coronary angiogenesis after myocardial infarction. Cardiology. 83:1993;212-216.
46. Rentrop K.P., Feit F., Sherman W., Thornton J.C. Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction. Report from the second Mount Sinai-New York University Reperfusion Trial. Circulation. 80:1989;1166-1175.
47. Shen W.F., Cui L.Q., Gong L.S., Lesbre J.P. Beneficial effect of residual flow to the infarct region on left ventricular volume changes after acute myocardial infarction. Am Heart J. 119:(3 Pt 1):1990;525-529.
48. Nohara R., Kambara H., Murakami T., et al. Collateral function in early acute myocardial infarction. Am J Cardiol. 52:1983;955-959.
49. Schwartz H., Leiboff R.L., Katz R.J., et al. Arteriographic predictors of spontaneous improvement in left ventricular function after myocardial infarction. Circulation. 71:1985;466-472.
50. Habib G.B., Heibig J., Forman S.A., et al. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation. 83:1991;739-746.
51. Topol E.J., Ellis S.G. Coronary collaterals revisited. Accessory pathway to myocardial preservation during infarction. Circulation. 83:1991;1084-1086.
52. Li J., Brown L.F., Hibberd M.G., et al. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol. 270:(5 Pt 2):1996;H1803-1811.
53. Kawamoto A., Kawata H., Akai Y., et al. Serum levels of VEGF and basic FGF in the subacute phase of myocardial infarction. Int J Cardiol. 67:(1):1998;47-54.
54. Esch F., Baird A., Ling N., et al. Primary structure of bovine brain acidic fibrolast growth factor. Bochem Biophys Res Commun. 133:1985;554-562.
55. Zhu X., Komiya H., Chirino A., et al. Three-dimensional structures of acidic and basic fibroblast growth factors. Science. 251:1991;90-93.
56. Jaye M., Howk R., Burgess W., et al. Human endothelial cell growth factor: cloning, nucleotide sequence, and chromosome localization. Science. 233:1986;541-545.
57. Gospodarowicz D. Fibroblast growth factor. Crit Rev Oncog. 1:1989;1-26.
58. Abraham J.A., Mergia A., Whang J.L., et al. Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science. 233:1986;545-548.
59. Abraham J.A., Whang J.L., Tumolo A., Mergia A., Fiddes J.C. Human basic fibroblast growth factor: nucleotide sequence, genomic organization, and expression in mammalian cells. Cold Spring Harb Symp Quant Biol. 51:1986;657-668.
60. Mergia A., Eddy R., Abraham J.A., Fiddes J.C., Shows T.B. The genes for basic and acidic fibroblast growth factors are on different human chromosomes. Biochem Biophys Res Commun. 138:1986;644-651.
61. Abraham J.A., Whang J.L., Tumolo A., et al. Human basic fibroblast growth factor: nucleotide sequence and genomic organization. EMBO J. 5:1986;2523-2528.
62. Imamura T., Engleka K., Zhan X., et al. Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence. Science. 249:1990;1567-1570.
63. Florkiewicz R.Z., Sommer A. Human basic fibroblast growth factor gene encodes four polypeptides: Three initiate translation from non-AUG codons. Proc Natl Acad Sci USA. 86:1989;3978-3981.
64. Quarto N., Finger F.P., Rifkin D.B. The NH2-terminal extension of high molecular weight bFGF is a nuclear targeting signal. J Cell Physiol. 147:1991;311-318.
65. Cattini P.A., Nickel B.E., Klassen M.E., Kardami E. Immunolocalization of basic fibroblast growth factor (bFGF) in growing and growth-inhibited placental cells: a possible role for bFGF in placental cell development. Placenta. 12:1991;341-352.
66. Burgess W.H., Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem. 58:1989;575-606.
67. Baird A., Ling N. Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vivo: implications for a role of heparinase-like enzymes in a neovascular response. Biochem Biophys Res Commun. 142:1987;428-435.
68. Humbel R.E. Insulin-like growth factors I and II. Eur J Biochem. 190:1990;445-462.
69. Neff N.T., Prevette D., Houenou L.J., et al. Insulin-like growth factors: putative muscle-derived trophic agents that promote motoneuron survival. J Neurobiol. 24:1993;1578-1588.
70. Steenbergh P.H., Koonen-Reemst A.M., Cleutjens C.B., Sussenbach J.S. Complete nucleotide sequence of the high molecular weight human IGF-I mRNA. Biochem Biophys Res Commun. 175:1991;507-514.
71. de Pagter-Holthuizen P., Jansen M., van der Kammen R.A., et al. Differential expression of the human insulin-like growth factor II gene. Characterization of the IGF-II mRNAs and an mRNA encoding a putative IGF-II-associated protein. Biochim Biophys Acta. 950:1988;282-295.
72. Clemmons D.R. IGF binding proteins: regulation of cellular actions. Growth Regul. 2:1992;80-87.
73. Grant M.B., Mames R.N., Fitzgerald C., et al. Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor. Diabetologia. 36:1993;282-291.
74. Lynch S.E., Colvin R.B., Antoniades H.N. Growth factors in wound healing. Single and synergistic effects on partial thickness porcine skin wounds. J Clin Invest. 84:1989;640-646.
75. Pasyk S., Schaper W., Schaper J., et al. DNA synthesis in coronary collaterals after coronary artery occlusion in conscious dog. Am J Physiol. 242:1982;H1031-H1037.
76. Schaper W., De Brabander M., Lewi P. DNA synthesis and mitoses in coronary collateral vessels of the dog. Circ Res. 28:1971;671-679.
77. Montesano R. Regulation of angiogenesis in vitro. Eur J Clin Invest. 22:1992;504-515.
78. Montesano R., Vassalli J.D., Baird A., Guillemin R., Orci L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA. 83:1986;7297-7301.
79. Miyataka M., Ishikawa K., Katori R. Basic fibroblast growth factor increased regional myocardial blood flow and limited infarct size of acutely infarcted myocardium in dogs. Angiology. 49:1998;381-390.
80. Hasegawa T., Kimura A., Miyataka M., Inagaki M., Ishikawa K. Basic fibroblast growth factor increases regional myocardial blood flow and salvages myocardium in the infarct border zone in a rabbit model of acute myocardial infarction. Angiology. 50:(6):1999;487-495.
81. Watanabe E., Smith D.M., Sun J., et al. Effect of basic fibroblast growth factor on angiogenesis in the infarcted porcine heart. Basic Res Cardiol. 93:1998;30-37.
82. Scheinowitz M., Kotlyar A., Zimand S., et al. Basic fibroblast growth factor induces myocardial hypertrophy following acute infarction in rats. Exp Physiol. 83:1998;585-593.
83. Scheinowitz M., Abramov D., Kotlyar A., Savion N., Eldar M. Continuous administration of insulin-like growth factor-I and basic fibroblast growth factor does not affect left ventricular geometry after acute myocardial infarction in rats. Int J Cardiol. 63:1998;217-221.
84. Padua R.R., Sethi R., Dhalla N.S., Kardami E. Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injury. Mol Cell Biochem. 143:1995;129-135.
85. Anderson K.J., Dam D., Lee S., Cotman C.W. Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo. Nature. 332:1988;360-363.
86. Horrigan M.C., MacIsaac A.I., Nicolini F.A., et al. Reduction in myocardial infarct size by basic fibroblast growth factor after temporary coronary occlusion in a canine model. Circulation. 94:1996;1927-1933.
87. Saraste A., Pulkki K., Kallajoki M., et al. Apoptosis in human acute myocardial infarction. Circulation. 95:1997;320-323.
88. Cuevas P., Reimers D., Carceller F., et al. Fibroblast growth factor-1 prevents myocardial apoptosis triggered by ischemia reperfusion injury. Eur J Med Res. 2:1997;465-468.
89. Htun P., Ito W.D., Hoefer I.E., Schaper J., Schaper W. Intramyocardial infusion of FGF-1 mimics ischemic preconditioning in pig myocardium. J Mol Cell Cardiol. 30:1998;867-877.
90. Lee W.L., Chen J.W., Ting C.T., Lin S.J., Wang P.H. Changes of the insulin-like growth factor I system during acute myocardial infarction: implications on left ventricular remodeling. J Clin Endocrinol Metab. 84:(5):1999;1575-1581.
91. Li Q., Li B., Wang X., et al. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest. 100:(8):1997;1991-1999.
92. Battler A., Hasdai D., Goldberg I., et al. Exogenous insulin-like growth factor II enhances post-infarction regional myocardial function in swine. Eur Heart J. 16:1995;1851-1859.
93. Duerr R.L., Huang S., Miraliakbar H.R., et al. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest. 95:(2):1995;619-627.
94. Kluge A., Zimmermann R., Munkel B., et al. Insulin-like growth factor II. is an experimental stress inducible gene in a porcine model of brief coronary occlusions. Cardiovasc Res. 29:1995;708-716.
95. Vogt A.M., Htun P., Kluge A., Zimmermann R., Schaper W. Insulin-like growth factor-II delays myocardial infarction in experimental coronary artery occlusion. Cardiovasc Res. 33:1997;469-477.
96. Buerke M., Murohara T., Skurk C., Nuss C., Tomaselli K., Lefer A.M. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci USA. 92:1995;8031-8035.
97. Reimer K.A., Jennings R.B., Cobb F.R., et al. Animal models for protecting ischemic myocardium: results of the NHLBI cooperative study. Comparison of unconscious and conscious dog models. Cir Res. 56:1985;651-665.
98. Unger E.F., Sheffield C.D., Epstein S.E. Heparin promotes the formation of extracardiac to coronary anastomoses in a canine model. Am J Physiol. 260:(5 Pt 2):1991;H1625-H1634.
99. Unger E.F., Shou M., Sheffield C.D., et al. Extracardiac to coronary anastomoses support regional left ventricular function in dogs. Am J Physiol. 264:(5 Pt 2):1993;H1567-H1574.
100. Fujita M., Mikuniya A., Takahashi M., et al. Acceleration of coronary collateral development by heparin in conscious dogs. Jpn Circ J. 51:1987;395-402.
101. Thompson R.W., Whalen G.F., Saunders K.B., Hores T., D'Amore P.A. Heparin-mediated release of fibroblast growth factor-like activity into the circulation of rabbits. Growth Factors. 3:1990;221-229.
102. Gospodarowicz D., Cheng J. Heparin protects basic and acidic FGF from inactivation. J Cell Physiol. 128:1986;475-484.
103. Damon D.H., Lobb R.R., D'Amore P.A., Wagner J.A. Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biologic half-life. J Cell Physiol. 138:1989;221-226.
104. Mueller S.N., Thomas K.A., Di Salvo J., Levine E.M. Stabilization by heparin of acidic fibroblast growth factor mitogenicity for human endothelial cells in vitro. J Cell Physiol. 140:1989;439-448.